Jun 16, 2022 // Study Updates
Nicholas Cheng provides an overview of his study on identifying early cancer biomarkers in pre-diagnosis blood samples collected from more than 400 OHS participants. He demonstrates how blood signatures can be used to detect breast, prostate and pancreatic cancers years prior to clinical detection using cfDNA methylation profiles. Kimberly Skead describes her work studying how the interacting
May 4, 2022 // Study Updates
What makes the OHS platform such a useful resource for researchers? OHS Scientific Associate and Epidemiologist Dr. Victoria Kirsh explains what makes the Study so unique: The OHS is designed specifically for investigator-initiated research The OHS enables both retrospective and prospective research The OHS is Ontario’s largest biobank, and is the largest contributing cohort to
Apr 1, 2022 // Study Updates
Submitting a fully-completed OHS Data Access Application saves you time and additional work, allowing you to begin your research that much quicker. The OHS Research Operations and Access Officer provides some helpful tips to ensure your access request is successful.
Mar 23, 2022 // Study Updates
Beginning December 2020, select CanPath participants were invited to complete a follow-up COVID-19 questionnaire and submit dried blood spot samples. The questionnaire included details around vaccination, previous COVID-19 infection, underlying medical conditions, and medications taken. Dried blood spot samples were tested for antibodies to SARS-CoV-2 (anti-spike IgG, anti-receptor binding domain of spike (RBD) IgG, and anti-nucleocapsid (N) IgG). Collection